Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 2/20 | 0.62 |
| ▸ | ARG2 | P78540 | 2/20 | 0.62 |
| ▸ | GGT1 | P19440 | 1/20 | 0.52 |
| ▸ | ODC1 | P11926 | 2/20 | 0.45 |
| ▸ | BLM | P54132 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PLG | P00747 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL161423 | 1.00 | ARG1 (0.62) | ARG1ARG2GGT1ODC1BLM | |
| SCHEMBL201390 | 1.00 | ARG1 (0.62) | ARG1ARG2GGT1ODC1BLM | |
| SCHEMBL23733387 | 0.98 | ARG1 (0.60) | ARG1ARG2GGT1ODC1BLM | |
| SCHEMBL5320545 | 0.98 | ARG1 (0.60) | ARG1ARG2GGT1ODC1BLM | |
| SCHEMBL5325205 | 0.98 | ARG1 (0.60) | ARG1ARG2GGT1ODC1BLM | |
| SCHEMBL162369 | 0.93 | ARG1 (0.59) | ARG1ARG2GGT1ODC1BLM | |
| SCHEMBL162370 | 0.93 | ARG1 (0.59) | ARG1ARG2GGT1ODC1BLM | |
| SCHEMBL574141 | 0.93 | ARG1 (0.59) | ARG1ARG2GGT1ODC1BLM | |
| Hydrochloric Acid SCHEMBL3219766 | 0.91 | ARG1 (0.57) | ARG1ARG2GGT1ODC1BLM | |
| Water SCHEMBL7726696 | 0.91 | ARG1 (0.57) | ARG1ARG2GGT1ODC1BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 553 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025109003-A1 | P-CADHERIN LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-05-30 | — | — | WO | claimed |
| EP-4482578-A1 | CRF2 RECEPTOR AGONISTS AND THEIR USE IN THERAPY | Corteria Pharmaceuticals (FR) | 2025-01-01 | — | — | EP | claimed |
| CN-118843638-A | CRF2 receptor agonists and their use in therapy | 科尔特瑞制药公司 | 2024-10-25 | — | — | CN | claimed |
| CN-116804046-B | Cyclic cation antibacterial peptide and application thereof | 科睿铂泰医药科技(深圳)有限责任公司 | 2024-07-16 | — | — | CN | claimed |
| EP-4392440-A2 | COMBINATION OF RELAXIN AND VASOPRESSIN ANALOGUES FOR TREATMENT OF RENAL DISORDERS OR CONDITIONS | River 2 Renal Corp. (US) | 2024-07-03 | — | — | EP | claimed |
| CN-116804046-A | Cyclic cation antibacterial peptide and application thereof | 科睿铂泰医药科技(深圳)有限责任公司 | 2023-09-26 | — | — | CN | claimed |
| EP-4237427-A1 | ANTIBACTERIAL CYCLOPEPTIDES TARGETING ACINETOBACTER AND OTHER GRAM-NEGATIVE PATHOGENS | University of Utah Research Foundation (US) | 2023-09-06 | — | — | EP | claimed |
| WO-2023161229-A1 | CRF2 RECEPTOR AGONISTS AND THEIR USE IN THERAPY | CORTERIA PHARMACEUTICALS (FR) | 2023-08-31 | — | — | WO | claimed |
| EP-4234574-A1 | CRF2 RECEPTOR AGONISTS AND THEIR USE IN THERAPY | Corteria Pharmaceuticals (FR) | 2023-08-30 | — | — | EP | claimed |
| CN-116670151-A | Antibacterial cyclic peptides targeting acinetobacter and other gram negative pathogens | 犹他大学研究基金会 | 2023-08-29 | — | — | CN | claimed |
| WO-2015084921-A1 | CLEANING FORMULATION FOR REMOVING RESIDUES ON SURFACES | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2015-06-11 | — | — | WO | claimed |
| US-20150159124-A1 | CLEANING FORMULATION FOR REMOVING RESIDUES ON SURFACES | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. | 2015-06-11 | — | — | US | claimed |
| WO-2015060954-A1 | CLEANING FORMULATIONS FOR REMOVING RESIDUES ON SURFACES | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2015-04-30 | — | — | WO | claimed |
| US-20150111804-A1 | CLEANING FORMULATIONS FOR REMOVING RESIDUES ON SURFACES | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. | 2015-04-23 | — | — | US | claimed |
| US-20120121591-A1 | SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3 | AMGEN INC. (US) | 2012-05-17 | — | — | US | claimed |
| EP-2432488-A2 | SELECTIVE AND POTENT PEPTIDE INHIBITORS OF KV1.3 | Amgen, Inc (US) | 2012-03-28 | — | — | EP | claimed |
| WO-2010108154-A2 | SELECTIVE AND POTENT PEPTIDE INHIBITORS OF KV1.3 | AMGEN INC. (US) | 2010-09-23 | — | — | WO | claimed |
| WO-2008077194-A1 | RECEPTOR AGONISTS | XENOME LTD (AU) | 2008-07-03 | — | — | WO | claimed |
| WO-2006052637-A1 | RETROCYCLINS: ANTIVIRAL AND ANTIMICROBIAL PEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-05-18 | — | — | WO | claimed |
| US-4066501-A | CORYNEBACTERIA, BREVIBACTERIA | AJINOMOTO CO., INC. (JA) | 1978-01-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120121591-A1 | SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3 | KCNJ4, KCNK4, KCNQ4 | ARG1 2721/4885ARG2 2689/4885GGT1 4560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.